These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 23289352)
1. Nanofiber-based delivery of therapeutic peptides to the brain. Mazza M; Notman R; Anwar J; Rodger A; Hicks M; Parkinson G; McCarthy D; Daviter T; Moger J; Garrett N; Mead T; Briggs M; Schätzlein AG; Uchegbu IF ACS Nano; 2013 Feb; 7(2):1016-26. PubMed ID: 23289352 [TBL] [Abstract][Full Text] [Related]
2. Peptide nanofiber complexes with siRNA for deep brain gene silencing by stereotactic neurosurgery. Mazza M; Hadjidemetriou M; de Lázaro I; Bussy C; Kostarelos K ACS Nano; 2015 Feb; 9(2):1137-49. PubMed ID: 25574683 [TBL] [Abstract][Full Text] [Related]
3. A strategy for delivering peptides into the central nervous system by sequential metabolism. Bodor N; Prokai L; Wu WM; Farag H; Jonalagadda S; Kawamura M; Simpkins J Science; 1992 Sep; 257(5077):1698-700. PubMed ID: 1529356 [TBL] [Abstract][Full Text] [Related]
4. Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. Rousselle C; Clair P; Smirnova M; Kolesnikov Y; Pasternak GW; Gac-Breton S; Rees AR; Scherrmann JM; Temsamani J J Pharmacol Exp Ther; 2003 Jul; 306(1):371-6. PubMed ID: 12682214 [TBL] [Abstract][Full Text] [Related]
5. Transition from vesicles to nanofibres in the enzymatic self-assemblies of an amphiphilic peptide as an antitumour drug carrier. Gong Z; Liu X; Dong J; Zhang W; Jiang Y; Zhang J; Feng W; Chen K; Bai J Nanoscale; 2019 Sep; 11(33):15479-15486. PubMed ID: 31237302 [TBL] [Abstract][Full Text] [Related]
6. Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes. Popov M; Abu Hammad I; Bachar T; Grinberg S; Linder C; Stepensky D; Heldman E Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):381-9. PubMed ID: 23791683 [TBL] [Abstract][Full Text] [Related]
7. Amphiphilic Endomorphin-1 Derivative Functions as Self-assembling Nanomedicine for Effective Brain Delivery. Liu H; Zhao X; Liang S; Fan L; Li Z; Zhang Y; Ni J Chem Pharm Bull (Tokyo); 2019; 67(9):977-984. PubMed ID: 31474737 [TBL] [Abstract][Full Text] [Related]
8. Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood-brain barrier in rats. Valiante S; Falanga A; Cigliano L; Iachetta G; Busiello RA; La Marca V; Galdiero M; Lombardi A; Galdiero S Int J Nanomedicine; 2015; 10():1885-98. PubMed ID: 25792823 [TBL] [Abstract][Full Text] [Related]
9. Supramolecular nanofibers of self-assembling peptides and proteins for protein delivery. Wang H; Wang Y; Zhang X; Hu Y; Yi X; Ma L; Zhou H; Long J; Liu Q; Yang Z Chem Commun (Camb); 2015 Sep; 51(75):14239-42. PubMed ID: 26264079 [TBL] [Abstract][Full Text] [Related]
10. Shape-specific nanofibers via self-assembly of three-branched peptide. Koga T; Matsui H; Matsumoto T; Higashi N J Colloid Interface Sci; 2011 Jun; 358(1):81-5. PubMed ID: 21429499 [TBL] [Abstract][Full Text] [Related]
11. Peptides and Drug Delivery. Ulapane KR; Kopec BM; Moral MEG; Siahaan TJ Adv Exp Med Biol; 2017; 1030():167-184. PubMed ID: 29081054 [TBL] [Abstract][Full Text] [Related]
12. Cathepsin nanofiber substrates as potential agents for targeted drug delivery. Ben-Nun Y; Fichman G; Adler-Abramovich L; Turk B; Gazit E; Blum G J Control Release; 2017 Jul; 257():60-67. PubMed ID: 27908759 [TBL] [Abstract][Full Text] [Related]
13. Peptide pills for brain diseases? Reality and future perspectives. Serrano Lopez DR; Lalatsa A Ther Deliv; 2013 Apr; 4(4):479-501. PubMed ID: 23557289 [TBL] [Abstract][Full Text] [Related]
14. Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration. Lalatsa A; Schätzlein AG; Garrett NL; Moger J; Briggs M; Godfrey L; Iannitelli A; Freeman J; Uchegbu IF J Control Release; 2015 Jan; 197():87-96. PubMed ID: 25449808 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier. Schroeder U; Sommerfeld P; Sabel BA Peptides; 1998; 19(4):777-80. PubMed ID: 9622035 [TBL] [Abstract][Full Text] [Related]
16. Lipopeptide delivery of siRNA to the central nervous system. Zabel MD Methods Mol Biol; 2013; 948():251-62. PubMed ID: 23070775 [TBL] [Abstract][Full Text] [Related]
17. Polymersomes conjugated with des-octanoyl ghrelin for the delivery of therapeutic and imaging agents into brain tissues. Chen YC; Chiang CF; Chen LF; Liao SC; Hsieh WY; Lin WL Biomaterials; 2014 Feb; 35(6):2051-65. PubMed ID: 24315575 [TBL] [Abstract][Full Text] [Related]
18. A peptide derived from melanotransferrin delivers a protein-based interleukin 1 receptor antagonist across the BBB and ameliorates neuropathic pain in a preclinical model. Thom G; Tian MM; Hatcher JP; Rodrigo N; Burrell M; Gurrell I; Vitalis TZ; Abraham T; Jefferies WA; Webster CI; Gabathuler R J Cereb Blood Flow Metab; 2019 Oct; 39(10):2074-2088. PubMed ID: 29845881 [TBL] [Abstract][Full Text] [Related]
19. Nanofibrous scaffold from self-assembly of beta-sheet peptides containing phenylalanine for controlled release. Zhao Y; Tanaka M; Kinoshita T; Higuchi M; Tan T J Control Release; 2010 Mar; 142(3):354-60. PubMed ID: 19932721 [TBL] [Abstract][Full Text] [Related]
20. Challenges and new strategies for therapeutic peptide delivery to the CNS. McGowan JW; Bidwell GL; Vig PJ Ther Deliv; 2015 Jul; 6(7):841-53. PubMed ID: 26228775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]